The effect of the benzodiazepine antagonist flumazenil on regional cerebral blood flow in human volunteers. 1990

J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
Department of Anaesthsia, Bispebjerg Hospital, Copenhagen, Denmark.

The influence of the benzodiazepine antagonist flumazenil on regional cerebral blood flow (rCBF) was investigated in ten healthy, alert volunteers. The design was a randomized, placebo-controlled, double-blind, cross-over study. rCBF was measured by 133-Xe inhalation and single photon emission computerized tomography, SPECT, immediately before, and 5 and 35 min after intravenous injection of flumazenil 1.0 mg or placebo. In addition, mean arterial blood pressures or PaCO2, rCBF were analysed for changes in various regions of interest (RoI). No alterations were found either in the global CBF or in rCBF in RoI after flumazenil injection. The results showed that a clinically active dose of flumazenil did not directly affect the cerebral circulation in the normal brain and indicated absence of significant intrinsic activity of the drug.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005442 Flumazenil A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Flumazepil,Anexate,Lanexat,Ro 15-1788,Romazicon,Ro 15 1788,Ro 151788

Related Publications

J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
January 1988, Gerontology,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
October 1990, Journal of cardiovascular pharmacology,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
March 2008, Anesthesia and analgesia,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
September 1993, Clinical pharmacy,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
October 1988, BMJ (Clinical research ed.),
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
October 1990, DICP : the annals of pharmacotherapy,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
May 1989, Drug and therapeutics bulletin,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
September 1988, Dental update,
J Wolf, and L Friberg, and J Jensen, and P B Hansen, and A R Andersen, and N A Lassen
August 1993, Psychological medicine,
Copied contents to your clipboard!